Betadine 10% Ointment (Povidone Iodine) – Antiseptic Infection Treatment
Buy Betadine 10% Ointment from Tabexports – Global Medicine Supplier
Betadine 10% Ointment (Povidone Iodine) is a topical antiseptic medication used for the prevention and treatment of minor skin infections, cuts, wounds, burns, and abrasions. The active ingredient Povidone Iodine 10% provides broad-spectrum antimicrobial protection, effectively killing bacteria, fungi, viruses, and protozoa.
Tabexports supplies Betadine 10% Ointment for international pharmaceutical markets, offering bulk export, wholesale supply, and reliable worldwide delivery to the United States, United Kingdom, Australia, France, Thailand, and other global regions.
Active Ingredient
-
Povidone Iodine 10%
Povidone iodine is a powerful antiseptic and disinfectant agent widely used in medical and first-aid treatments to prevent infection in wounds.
Medical Uses
✔ Treatment of minor cuts and wounds
✔ Prevention of skin infections
✔ Management of burns and abrasions
✔ Pre-operative skin disinfection
✔ Protection against microbial contamination
⚠ Use according to medical advice.
Key Benefits
-
Broad-spectrum antimicrobial activity
-
Helps prevent wound infections
-
Fast-acting antiseptic formula
-
Suitable for hospitals, clinics, and home first aid
-
Trusted worldwide antiseptic treatment
Directions for Use
-
Clean the affected area gently.
-
Apply a thin layer of Betadine 10% Ointment to the skin.
-
Cover with sterile dressing if required.
-
Repeat as directed by a healthcare professional.
Storage
-
Store below 25°C
-
Keep away from moisture and direct sunlight
-
Keep out of reach of children
Why Buy from Tabexports?
🌍 Global pharmaceutical exporter
📦 Bulk medicine supply for distributors
🚚 Worldwide delivery support
🏥 Reliable sourcing of quality medicines
📈 Trusted by pharmacies and wholesalers internationally
Tabexports exports Betadine 10% Ointment (Povidone Iodine) to USA, UK, Australia, France, Thailand, and worldwide pharmaceutical markets.





Reviews
There are no reviews yet.